4
Changes in Ownership
Mentari Therapeutics, Inc. Filed Acc 0001213900-22-080983
Options or other derivatives
- Chief Operating Officer acquired 7,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
WOUDENBERG MICHAEL · Chief Operating Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-12-16 | Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) | +7,500 | 11,342 | D |
Loading xslF345X03/ownership.xml…